Klaus G. Parhofer

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes et al. · European Heart Journal · 2022 · 1.1K citations · Full text

Vascular Disease, Cardiometabolic Risk, Hyperlipidemia +22

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Marina Cuchel, Éric Bruckert, Henry N. Ginsberg et al. · European Heart Journal · 2014 · 1K citations · Full text

Defining high-fat-diet rat models: metabolic and molecular effects of different fat types

Roland Buettner, Klaus G. Parhofer, Matthias Woenckhaus et al. · Journal of Molecular Endocrinology · 2006 · 691 citations · Full text

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

Michael Lehrke, Alexander Becker, Martin Greif et al. · European Journal of Endocrinology · 2009 · 294 citations

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10